Irene Maria Briata

10PUBLICATIONS
71CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsModels of care and place of birthClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 19, 2026
Biomarker Modulation by Aspirin and Metformin for Colorectal Cancer Prevention: Results from the ASAMET Randomized Phase II Trial.

|Oct 30, 2025
Time-Restricted Eating and Metformin in Invasive Breast Cancer or DCIS: A Randomized, Phase IIb, Presurgical Trial. Preliminary Safety Analysis.

Irene Maria Briata, Stefano Spinaci, Parijatham S Thomas

|Jun 09, 2025
Window-of-opportunity trials to screen effective agents and optimize dose in breast cancer prevention.

G Aurilio, D Serrano, M Lazzeroni

|Apr 28, 2025
Predictive Effect of IGFBP-3 on Low-Dose Tamoxifen Efficacy in Noninvasive Breast Cancer in the Phase III Tam-01 Trial.

Harriet Johansson, Debora Macis, Martino Oliva

|Dec 17, 2024
Effect of Distress, Anxiety, and Depressive Symptoms on SARS-CoV-2 mRNA BNT162b2 Vaccine Efficacy in Cancer Patients.

Gabriella Rondanina, Tania Buttiron Webber, Oriana D'Ecclesiis

|Jan 18, 2024
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.

Harriet Johansson, Aliana Guerrieri-Gonzaga, Sara Gandini

Pageof 2

Frequent Collaborators

10 joint publications

Andrea DeCensi

7 joint publications

Tania Buttiron-Webber

6 joint publications

Bernardo Bonanni

5 joint publications

Davide Serrano